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ABTRACT
The thalamic reticular nucleus (TRN) filters somatosensory stimuli by providing inhibition to the
excitatory thalamic relay nuclei, which then communicate with the cortex to appropriately
integrate and respond to sensory stimuli. The TRN is also responsible for generating and
maintaining sleep spindles, which are important for memory and cognition, and are disrupted in
various psychiatric disorders. Previous studies have shown that the TRN is comprised of several
neuronal subpopulations that carry out specific functions. These neurons can be distinguished
using peptide markers such as parvalbumin (PV), somatostatin (SST), and calbindin (CB). In this
thesis, I identified a novel neuronal population in the TRN that expresses the peptide
cholecystokinin (CCK) and distal-less homeobox gene 5/6 (Dlx5/6). CCK;Dlx5/6 neurons have
been widely studied in the hippocampus and amygdala where they have been shown to highly
express the type 1 cannabinoid receptor (CB1R) and produce a long-lasting inhibition of pyramidal
neurons. However, basic characterization of CCK;Dlx5/6 neurons has been missing. Through
immunohistochemical assays, we found that CCK;Dlx5/6 neurons of the TRN express CB1R and
the CCK peptide. Our results show that CCK;Dlx5/6 are highly concentrated in the dorsal areas of
the TRN relative to the ventral ones, dorsal areas of the TRN are associated with processing of
visual cues. Our preliminary results also show that dorsal and ventromedial areas of the thalamus
receive more inputs from CCK;Dlx5/6 neurons than ventral and medial thalamic areas.
Furthermore, some of the CCK;Dlx5/6 neurons establish perisomatic synapses with neurons of the
lateral dorsal nucleus of the thalamus, this type of connectivity is consistent with previous
observations for CCK neurons in amygdala and hippocampus. Taken together our results provide
insights into the anatomy of CCK;Dlx5/6 neurons that suggest a potential role of these neurons in
visual processing.

viii

1. INTRODUCTION

1.1 Sensory processing in both physiological and pathological conditions
Sensory processing depends on the proper functioning of peripheral sensory receptors that
transform environmental cues into electrical signals that can then be interpreted at the central level.
Sensory information passes through the thalamus before reaching the cortex where they ultimately
lead to a response (Sherman & Guillery, 2002). Sensory processing is the foundation for selective
attention and the proper perception of reality, which depends on a balance of excitation and
inhibition within the brain as too much excitation and/or too little inhibition can lead to the
perception of non-salient stimuli (Foss-Feig et al., 2017; Zheng, Matsuo, Miyamoto, & Hoshino,
2014). The inability to properly process sensory information, whether that be hypersensitivity or
hyposensitivity, is at the core of many neurological and neurodevelopmental disorders and is
thought to be a consequence of excitation-inhibition imbalance (Kang et al., 2019;Rubenstein &
Merzenich, 2003; Foss-Feig et al., 2017).
Attention deficit disorder with or without hyperactivity (ADD and ADHD) are defined by
cognitive rigidity, impulsivity, and inattention according the American Psychological Association
(American Psychiatric Association, 2013). Children with ADHD often suffer from comorbid
autism spectrum disorders (ASD) (Naaijen et al., 2017), which are largely characterized by having
deficits with social communication and the presence of repetitive behaviors (American Psychiatric
Association, 2013 ). Another common symptom of ASD is sensory over-responsivity, which is
associated with higher severity of social and repetitive behaviors (Ben-Sasson et al., 2008; Green
et al., 2018). Attention deficits and disrupted sensory processing seen in ADHD and ASD are also
common in patients with schizophrenia (McGhie & Chapman, 1961;Krol et al., 2018).
Schizophrenia (SCZ) is a debilitating psychiatric disorder with symptoms grouped into 3
1

categories: positive and negative symptoms. Positive symptoms include hallucinations, delusions,
and disorganized thoughts while negative symptoms refer to anhedonia, impaired social behavior,
and lack of emotional expression (Curley & Lewis, 2012). Cognitive processes such as working
memory are also dramatically impaired in schizophrenia (Carter et al., 2008;Curley & Lewis,
2012). In sum, a common factor amongst these disorders is some type of deficit in the numerous
circuits that contribute to proper sensation and perception including the cortico-thalamic circuitry.

1.2 Role of the thalamus in sensory processing
The thalamus was once thought to simply relay information from the periphery and sub-cortical
structures to the proper cortical destination has since been expanded upon. Before terminating in
the cortex, sensory information goes through circuits involving the thalamus such as
thalamocortical (TC), corticothalamic (CT), thalamo-thalamic circuits. The thalamus is made up
three functionally distinct types of nuclei: relay nuclei, intralaminar nuclei, and thalamic reticular
nucleus (TRN) (Veres, Linley, & Hoover, 2015). The relay nuclei represent the majority of
thalamic nuclei, are comprised of glutamatergic neurons, and are function/modality specific
(Figure 1). “Relay” refers to nuclei that are passing information between brain regions as opposed
to being the main drivers themselves or the ultimate destination of information (Crabtree, 2018).
Depending on the source of their driver input, thalamic relay nuclei are classified as first order
(FO) or higher order (HO). FO nuclei receive afferents from subcortical and peripheral sensory
structures (i.e. first in line of the sensory integration process), while HO nuclei receive afferents
from the cortex, mainly layer 5, and act as a means of communication between cortical areas (Lam
& Sherman, 2011;Crandall, Cruikshank, & Connors, 2015). The majority of these driver inputs
are excitatory (Pinault, 2004). The intralaminar nuclei process information from the brainstem
2

reticular formation and are involved in sensory-motor integration (Fisher & Reynolds, 2014).
Finally, and the main focus of my thesis is the TRN. In the section below, I will describe in detail
the neurobiology of this nucleus.

Figure 1. Anatomy of nuclei in the dorsal thalamus. The TRN wraps around FO and HO
relay nuclei. FO nuclei include the lateral geniculate nucleus (LGN), medial geniculate
nucleus (MGN), ventroposterolateral nucleus (VPL), ventral lateral nucleus (VL), and
ventral anterior nucleus (VA). HO nuclei include the medial dorsal nucleus (MD),
pulvinar (Pulv), and dorsolateral or laterodorsal nucleus (DL). (Pratt et al., 2016)

1.3 Functional organization of the thalamic reticular nucleus and its role in sensory
processing
In addition to driver inputs that carry specific information to relay nuclei, FO and HO nuclei
receive inhibitory and excitatory modulatory afferents that fine tune the information arriving to
these nuclei before it is relayed further. The excitatory modulator afferents originate from layer 6
of the cortex, whereas the inhibitory afferents originate from the TRN (Sherman & Guillery, 2002).
The TRN is the only thalamic nucleus comprised of entirely GABAergic neurons and is crucial in
controlling the excitation and gain of the thalamocortical transmission (Pinault, 2004). Both
3

descending afferents from the cortex to the thalamus (corticothalamic or CT) and ascending
efferents from the relay nuclei to layer 4 of the cortex (thalamocortical or TC) converge on the
TRN (Figure 2) (Crabtree & Isaac, 2002). This not only allows a way for cortical areas to
communicate with each other without direct innervation with one another, but also allows the same
for thalamic nuclei. The relay and interpretation of stimuli can go awry in either the CT or TC
pathways, but dysfunction in the TRN has the potential to disrupt both of these pathways. Also,
sensory processing relying on a delicate balance of excitation and inhibition puts a lot of focus on
the TRN. The importance of the TRN in sensory processes was established long ago when Francis
Crick said that if the thalamus is the gateway to the cortex then the TRN is considered the guardian
of that gateway (Crick, 1984).
As described above, the TRN participates in both feedforward and feedback processing of sensory
information in the form of LVI → TRN → TC neurons and TC neurons → TRN → TC neurons,
respectively (Crabtree, 2018). Aside from being the only GABAergic nucleus of the thalamus, the
TRN also differs from the other nuclei in the sense that it receives afferents from cortical and subcortical structures (so it is neither FO or HO) and only innervates thalamic relay nuclei (Pratt et
al., 2016). An example of these circuits working together to respond to stimulus is that of a visual
cue and is shown in Figure 2. The retina sends the visual information to the first-order lateral
geniculate nucleus (LGN). The LGN is innervated by the TRN and will provide inhibitory
feedback before the LGN passes this information to the visual cortex. The cortex then sends this
information back down the higher-order Pulvinar (Pulv) within the thalamus, also innervated by
the TRN (Pratt et al., 2016). This is of course a simplistic version of the circuit as it ignores other
sub-cortical modulatory inputs that contribute to determining the significance of the visual
information. In addition, the TRN is divided into sectors that correspond to specific sensory
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modalities that are connected to different relay nuclei associated with that sensory modality. In
particular, the dorsocaudal TRN is the visual sector, ventrocaudal is the auditory sector,
ventrocentral is the somatosensory sector, and lastly the least studied rostral motor sector
(Crabtree, 2018). A single TRN neuron can innervate more than one thalamic nucleus, but these
multiple thalamic nuclei are often functionally related to each other (Pinault & Deschênes, 1998).
This aspect is particularly important when considering attention to competing stimuli. An example
is the suppression of the visual TRN (connected to LGN) and activation of the auditory TRN
(connected to MGN) during a visual task with an auditory distractor (Wimmer et al., 2015).
Aside from receiving glutamatergic projections from layer 5 of the cortex (Zikopoulis & Barbas,

CT Pathway

TC Pathway

Figure 2. Simplified illustration of thalamocortical and corticothalamic pathways that
converge on the TRN when processing visual information from the eye. The LGN (FO nucleus)
receives driver input about visual stimuli from the retina as well as modulatory afferents from
cortical layer VI and the TRN. The LGN then terminates in cortical layers III and IV. The pulv (HO
nucleus) receives its driver input from cortical layer IV corresponding to the visual stimuli, as well
as modulatory afferents from cortical layer VI and the TRN. The pulv then innervates cortical layers
III and IV of the cortex. Created with BioRender.com
2007) and thalamic relay nuclei (Pinault, 2004), the TRN also receives GABAergic signals from
the lateral hypothalamus to regulate arousal (Hou et al., 2016), the globus pallidus (Gasca-
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Martinez et al., 2010), as well as cholinergic inputs from the basal forebrain (Pita-Almenar et al.,
2014), monoamergic and cholinergic afferents from the brain stem (Jones, 1991), and
dopaminergic afferents from the substantia nigra (Picazo et al., 2009). The amygdala has also been
shown to project directly to the TRN, with 70% of axons terminating in the rostral TRN, and be
important for emotional attention in monkeys (Zikopoulis & Barbas, 2012).
Cortical areas and associated specific relay nuclei corresponding to different somatosensory and
motor information form a topographic map onto the TRN (Pinault, 2004). Therefore, although FO
and HO thalamic relay nuclei may not communicate directly, the same sensory input driving them
will converge and be integrated in the TRN. To make matters even more complicated, the TRN
and relay nuclei can participate in both open and closed feedback loops. The closed loop consists
of a thalamic relay neuron projecting onto the TRN and the TRN then sending inhibitory input to
that thalamic relay neuron. The open loop is when a thalamic relay neuron projects onto the TRN
and then the TRN sends inhibitory input to a different thalamic relay neuron (Barbas & Zikopoulis,
2007). Additionally, TRN neurons innervate themselves in what is called lateral inhibition, and
this is thought to play a significant role in convergent sensory information from different sources
competing for attention (John et al., 2016). The complex role of the TRN in the integration of
information that is sent back and forth to the cortex makes this an exciting focus of study. I will
describe below the pathophysiology of the TRN.
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1.4 The thalamic reticular nucleus in health and disease
Given the key role of the TRN in the thalamus, it is not surprising that this nucleus has been linked
to the physiological functions related to sensory processing and to neurological conditions in which
this sensory processing is altered. The TRN has been reported to play a role in attention (Wells et
al., 2016; McAlonan et al., 2000;Weese et al., 1999; Zikopoulos & Barbas, 2006;Wimmer et al.,
2015), arousal (Lewis et al., 2015), pain sensitivity (Liu et al. 2017), memory consolidation via
the induction of sleep spindles (Latchoumane et al. 2017;), cognition and working memory
(Whissell et al., 2019), and motor processes (Villalobos et al., 2016).
Dysfunction of the TRN has been observed or strongly implicated to play a role in various
psychological disorders such ADD and ADHD (McAlonan et al., 2000;Wells et al., 2016), ASD
(Green et al., 2017;Wells et al., 2016), bipolar disorder (BPD) (Ferrarelli & Tononi, 2017;Steullet
et al., 2018), and SCZ (Ferrarelli & Tononi, 2017; Baran et al., 2019;Steullet et al., 2018; Young
& Wimmer, 2017). The TRN’s strategic position between the thalamus and cortex sets it up to be
a common denominator in these diseases.
Another characteristic that the disorders mentioned above share is abnormal sleep spindles. Sleep
spindles are synchronized oscillations in the frequency range of 9-16 Hz that occur in nonrapid
eye movement (NREM) sleep and are thought to support neuroplasticity and memory
consolidation (Latchoumane, Ngo, Born, & Shin, 2017). The TRN is well known to be the original
source of sleep spindles by changing their firing mode to bursts, deinactivating low-threshold
calcium channels and leading to rebound burst firing that ultimately activates the TRN (Piantoni
et al., 2016). Spindles can vary across samples in duration, amplitude, and frequency depending
upon the overall communication of the entire thalamocortical circuit, which then impact waking
brain activity (Bandarabadi et al., 2020).
7

The fact that sleep spindles can easily be measured makes them a promising biomarker for disease.
Lower sleep spindle intensity and amplitude in adolescents with ASD are associated with severity
of autistic traits (Merikanto et al., 2019). There are increased slow-spindle activity in children
diagnosed with ADHD (Saito et al., 2019). Many studies have found impairments in sleep spindle
density, amplitude, and duration in patients with chronic SCZ (reviewed in Kaskie et al., 2019).
Interestingly, patients experiencing the first-episode of psychosis, and therefore unmedicated, had
reduced spindle duration and intensity, but not amplitude (Kaskie et al., 2019). In addition, the
severity of spindle dysfunction in these first-episode in patients with SCZ predicted the severity
of the negative symptoms they would go on to form, indicating that quality of sleep spindles is
present as early as the onset of schizophrenia as opposed to be a product of chronic schizophrenia
(Kaskie et al., 2019). What exactly initiates these spindle abnormalities in psychiatric disorders is
unknown.

1.5 Neuronal populations within the thalamic reticular nucleus
Although all neurons in the TRN are GABAergic, different populations of cells have been
identified through peptide markers. The majority of neurons express the calcium-binding protein
parvalbumin (PV+) (Steullet et al., 2018; Alberi et al., 2013). The peptide somatostatin (SST+) and
calbindin (CB+) are also expressed in cells of the TRN (Pinault, 2004;Martinez-Garcia et al., 2020).
The neuropeptide cholecystokinin (CCK) was shown to be expressed in the TRN decades ago
(Sohal, Cox, & Huguenard, 1998), but little research has been done to understand function of cells
that express CCK (CCK+) in this area of the brain compared to PV+, CB+ and SST+ interneurons.
The importance of investigating these interneuron populations separately becomes clear when
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considering the individual differences of among them, with emphasis on different firing properties,
co-expressed receptors, and their ability to modulate one another (Table 1).
Protein/Peptide
Parvalbumin
(PV)

Cholecystokinin
(CCK)
Somatostatin
(SST)
Calbindin
(CB)

Electrophysiological
Properties
. Fast-spiking
. Non-adapting
. Synchronous release
. Controlled by P/Q type Ca
channels

Receptor
Subtypes
. NMDA
. 5-HT1A
. D2

. Unknown

. Unknown

. Regular spiking
. Slow, weak, less precise
than PV
. Low-threshold
. Regular Spiking

. Erbb4

. Unknown

Function
. Inhibit pyramidal
neurons via perisomatic
compartment
. Contribute to
synchronization of
oscillations
. Unknown
. Inhibit pyramidal
neurons at distal
dendrites
. Inhibit pyramidal
neurons typically at
dendritic sites

Table 1. Properties of neuronal populations classified according to peptide markers in the
TRN. Although these interneuron populations are well-defined in other areas of the brain, they
still remain relatively elusive in the TRN. N-methyl-D-aspartate receptor (NMDA), serotonin
receptor 1A (5-HT1A), dopamine receptor 2 (D2), receptor tyrosine-protein kinase subtype
(Erbb4).

The function of CCK+ interneurons within the TRN has not yet been determined. Part of this thesis
is to lay the groundwork to characterize the role of CCK+ interneurons in the function of the TRN.
Furthermore, because CCK+ interneurons in other brain areas are hugely enriched with the
cannabinoid receptor type 1 (CB1R), we also sought to generate preliminary evidence of the
potential role of these neurons in the regulation of the TRN by CB1R agonists.

9

1.6 Cholecystokinin-expressing interneurons and cannabinoid receptor type 1 in the
thalamic reticular nucleus
Endocannabinoids have been linked to the regulation of sleep states (Pava et al., 2014;Perescis et
al., 2020), pain sensitivity (Smith et al., 2017;Woodhams et al., 2017), anxiety (Smith et al.,
2017;Ruehle et al., 2012; Patel et al., 2017), and memory deficits (Smith et al., 2017; Volk &
Lewis, 2016). The two main endocannabinoids produced in the brain are anandamide and 2arachidonoyl glycerol (Cristino et al., 2020). These endocannabinoids bind to CB1 and CB2
receptors. The distribution of cannabinoid receptors across brain regions is highly conserved in
different species (Katona & Freund, 2012), further demonstrating the importance of this system.
CB1R has previously been shown to be expressed in the TRN (van Rijn et al., 2010), but the cell
type in which it is expressed has not been determined. In the rest of the brain CB1R is expressed
primarily on CCK+ interneurons (Katona et al., 1999;Omiya et al., 2015;Neu et al., 2007;Bowers
et al., 2014). And our lab replicated these results CCK+ interneurons express 100 fold more CB1R
transcript than pyramidal neurons (Bunda, LaCarubba, Akiki, & Andrade, 2019). Although, PV+
interneuron axon terminals have been found to express CB1R in the infralimbic prefrontal cortex
in small amounts (Liu, Dimidschstein, Fishell, & Carter, 2020) and excitatory terminals of
pyramidal neurons also express small amounts of CB1R (Liu et al., 2020). Activation of
CCK/CB1R neurons ultimately leads to suppression of neurotransmitter a process called
depolarization-induced suppression of inhibition or excitation depending on whether the
neurotransmitter is GABA or glutamate (DSI and DSE, respectively). Stimulation of the postsynaptic cell results in synthesis of endocannabinoids that travel back to the CCK/CB1R presynaptic neuron where it binds to CB1R and blocks calcium channels needed for neurotransmitter
release. In this sense, CB1R acts as a type of autoreceptor.
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1.7 Function of cholecystokinin-expressing interneurons in other areas of the brain
CCK+ interneurons have been widely studied in other areas of the brain, thus we can gain insight
about their function by reviewing the information about these neurons from other areas such as the
amygdala and hippocampus. In contrast to PV+ interneurons, CCK+ interneurons display regularspiking activity and asynchronous release of GABA via N-type calcium channels, leading to longlasting inhibition (Hefft and Jonas, 2005). Activation of CCK+ interneurons in the mouse brain
results in enhanced memory and cognition with no effect on emotional processing (Whissell et al.,
2019). A more region-specific activation of this same interneuron population within the basal
amygdala (BA) leads to modulation of fear extinction (Rovira-Esteban et al., 2019). CCK+
interneurons within the hippocampus express vasoactive intestinal polypeptide (VIP), vesicular
glutamate transporter type 3 (VGLUT3), somatic GABAB receptors, and 5-HT3 receptors (Freund,
2003). Furthermore, CCK+ interneurons in hippocampus and amygdala are enriched with large
amounts of the cannabinoid receptor 1 (CB1R) (Bowers & Ressler, 2014; Iball & Ali, 2011;
Katona et al., 1999; Lee, Földy, & Soltesz, 2010). Roughly 90% of CB1R expressing interneurons
within the CA1 region of are CCK+ (Jappy et al., 2016).

11

2.0 RESEARCH QUESTIONS
In this thesis, I performed a thorough histochemical characterization of genetically identified CCK
interneurons in the TRN. To do this, we labeled CCK interneurons using intersectional labeling
(Figure 3). An intersectional approach was necessary because the CCK promoter is active in both
excitatory and inhibitory neurons. In order to restrict the expression of the red fluorescence protein,
tdTomato (tdT) to CCK expressing interneurons we took advantage of the activity of the distalless homeobox 5/6 (Dlx5/6) promoter, which is specific of forebrain interneurons. In this approach,
two recombinases (Cre and Flpe) which expression depends on the CCK and Dlx5/6 promoters
respectively, excise two stop codons present before the start site of tdT. Thus, it is condition that
both promoters are active in the same cell to induce the expression of tdT (Taniguchi et al., 2011).
I will hereafter name this novel cell population as CCK;Dlx5/6 neurons.
I pursued the following research questions: Are CCK;Dlx5/6 cells in the TRN neurons? How are
CCK;Dlx5/6 neurons distributed across the anatomical regions of the TRN? Do CCK;Dlx5/6
neurons express the CCK peptide? Do CCK;Dlx5/6 neurons express the PV peptide? Do
CCK;Dlx5/6 neurons express CB1R similar to what has been observed in this neuronal type in the
amygdala and hippocampus? What are the likely synaptic targets of CCK;Dlx5/6 interneurons?
We expect that by answering these questions, we provide insights into the role of this novel cellpopulation in sensory processing at the TRN level.

12

3.0 METHODS
3.1 Animals
All procedures were approved by the Institutional Animal Care and Use Committee at the
University of New Hampshire (APPENDIX). To label CCK;Dlx5/6 neurons in the TRN, we
performed intersectional labeling. We obtained a triple transgenic mouse line containing alleles
for CCK-Cre, Dlx5/6-Flpe and tdT via breeding (Figure 3). Initially, Cck-Cre mice (012706; The
Jackson Laboratory) were crossed with Dlx5/6-Flpe mice (010815; The Jackson Laboratory). Cre

Figure 3. Breeding scheme to label CCK;Dlx5/6 cells in
the TRN. Top panel: homozygous CCK-IRES-cre mice are
first mated with Dlx5/6;Flpe mice. Middle panel: The
offspring of this mating produce CCK;Dlx5/6 mice, which
are then mated with tdT homozygous mice to produce
CCK;Dlx5/6;tdT progeny. Recombination of Cre-loxP and
Flpe-FRT remove both STOP cassettes and result in tdT
expression in GABAergic CCK+ cells.
and Flpe are recombinases expressed under the control of the CCK promoter and the Dlx5/6
promoter, respectively. Progeny from this initial cross, Cck-Cre; Dlx5/6-Flpe (abbreviated CCKDlx5/6), were dual transgenic mice with both alleles. Because mice with the Dlx5/6 alleles could
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not be bread to homozygosity, we selected for CCK-Dlx5/6 mice that were homozygous for CCKCre and heterozygous for Dlx5/6-Flpe. To optimize the recombination efficiency, male CCKDlx5/6 mice were bred to female mice containing a tdT allele downstream of two recombinase
target-flanked STOP cassettes (Ai65(RCFL-tdT)-D;021875; The Jackson Laboratory). The first
STOP cassette was flanked by loxP sites (recognized by Cre) and the second was flanked by FRT
sites (recognized by Flpe) (Figure 3). The resulting progeny had individuals with two distinct
genotypes: A) heterozygous for CCK-Cre and Ai65(RCFL-tdT)-D, but WT for Dlx5/6-Flpe, and
B) heterozygous for the three alleles (abbreviated CCK;Dlx5/6;tdT). In the latter mice, Cre-Lox
and Flpe-FRT recombination removed the two STOP cassettes, resulting in tdT fluorescence in
cells that expressed both CCK and Dlx5/6.

3.2 Genotyping
To differentiate between mice with genotype A and genotype B, we performed three PCR reactions
in genomic DNA. This was an extensive amount of work because entire litters needed to be
genotyped to select individuals with proper tdT expression. Briefly, genomic DNA was extracted
from P7-P9 animal tissue using Phire Animal Tissue Direct kit II (ThermoFisher Scientific,
F140WH) according to manufacturer instructions. PCR was performed with AmpliTaq Gold® 360
mastermix (Thermo Fisher Scientific, 4398881) using the following conditions: a hot start of 950
C for 10 min, followed by 35 cycles (950 C, 30 s; 600 C, 30 s; 720 C, 1 min), and a final step of 720
C for 7 min. Primers and expected products are shown in Table 2. Primers were added to the same
mixture for genotyping. Figure 4 shows typical PCR for mice with genotype A (lanes 1, 3, and 5),
and genotype B (lanes 2, 4, and 6). Note the presence of ~ 400 bp band in lane 2 that correspond
to the Dlx5/6-Flpe allele, a band of this size is absent in WT mice.
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Mouse
line
CCK-Cre

Dlx5/6-Flpe

Primers

Expected products

F-WT1: GGGAGGCAGATAGGATCACA
F-MT1: TGGTTTGTCCAAACTCATCAA
R: GAGGGGTCGTATGTGTGGTT
F-T1: CAGAATTGATCCTGGGGAGCTACG
R-T1: CCAGGACCTTAGGTGGTGTTTTAC
F-C: CAAATGTTGCTTGTCTGGTG
R-C: GTCAGTCGAGTGCACAGT TT

Hom: 180 bp
Het: 180 bp and 468 bp
WT: 468 bp
Transgene: 406 bp
PCR positive control:
200 bp
*PCR conditions do not
differentiate between
heterozygous and
homozygous mice
Hom: 196
Het: 196 and 297
WT: 297

Ai65(RCFL- F-WT2: AAGGGAGCTGCAGTGGAG TA
tdT)
R-WT2: CCGAAAATCTGTGGGAAG TC
R-MT1: GGCATTAAAGCAGCGTAT CC
F-MT2: CTGTTCCTGTACGGCATGG
All primers are reported in 5’ to 3’ direction
Table 2. Primers and expected products

Figure 4. PCR results from CCK;Dlx5/6;tdT mice. Mouse A genotype regarding each gene is
found in lanes 1 (200 bp), 3 (180 and 468 bp), and 5( 196 and 297 bp). This indicates that mouse
A is Dlx5/6-Flpe -/-, CCK-Cre +/-, tdT +/-. Mouse B genotype can be found in lanes 2 (200 and
406 bp), 4 (180 and 468 bp), and 6 (196 and 297 bp). In contrast to mouse A, mouse B contains the
transgene for Dlx5/6-Flpe in lane 2 at 406 bp, and therefore is Dlx5/6-Flpe +/-.
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3.3 Immunohistochemistry
Adult CCK;Dlx5/6;tdT mice of both sexes were deeply anesthetized in a chamber of isoflurane
(07-893-1389; Patterson Veterinary). After ensuring the absence of rear-foot reflex, an
intraperitoneal injection of 0.07 mL Euthasol® euthanasia solution (Virbac Animal Health, Co)
was given in the lower right abdomen with a 26-gauge needle. I next performed cardiac perfusion
with ice cold 1X PBS (1002657611; Sigma Aldrich), followed by ice cold 4% formalin solution
(HT501128; Sigma Aldrich), and followed again by ice cold PBS. The brains were then extracted
and stored in 4% formalin solution at 4˚ C for 24-48 hours. 50 µm coronal slices were prepared
using a vibratome (VT1000S; Leica) between -0.5 mm and -1.9 mm relative to Bregma to ensure
the entirety of the TRN was included. The slices were then kept in 12 well plates containing 1X
PBS and stored at 4˚ C overnight. The following day, slices were rinsed with PBS 3 times for 10
minutes while rotating (Roto Mix Type 50800; Thermolyne) to ensure removal of formalin
solution.
For CCK, PV and NeuN staining: Slices were then incubated in a blocking buffer consisting of
0.2% Triton-X (1002214179; Sigma Aldrich) in 1X PBS, 10% normal goat serum (ab7481;
Abcam), and 10% BSA (A9418; Sigma Aldrich) for 30-60 minutes while lightly rotating. The
slices were then rinsed with PBS for 10 minutes while rotating 3 times. The primary antibodies
rabbit polyclonal anti-CCK-8 (C2581; Sigma Aldrich), rabbit polyclonal anti-PV (ab11427;
Abcam), and/or mouse monoclonal anti-NeuN (MAB377; Sigma Aldrich) were added to the slices
sitting in blocking buffer mentioned above at a concentration of 1:1000. For CB1R staining,
permeabilization detergents were not used: slices were incubated in a blocking buffer that
consisted of 10% NGS in PBS for 2 hrs. They were then incubated in the same blocking solution
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containing the primary antibody extracellular rabbit polyclonal anti-CB1R (ACR-001; Alomone
labs) at 1:1000.
Slices were covered and left in 4˚C for 18-24 hours while rotating. The slices were then rinsed
again in PBS 3X, while lightly rotating, before adding the secondary antibodies Alexa488
(ab150077; Abcam) for rabbit primary antibodies, Alexa647 (ab150115; Abcam) for mouse
primary antibodies, and/or FITC (ab97239; Abcam) for mouse primary antibodies at a
concentration of 1:1000 in PBS to incubate for 2 hours in the dark, at room temperature, while
rotating. Slices were then rinsed again with PBS before adding the nuclear stain To-Pro-3 iodide
(T3605; inVitrogen) or SYTO-13 (S7575; Thermofisher) at a concentration of 1:1000 in PBS for
20 mins at room temperature. Slices were then rinsed another 3 times with PBS in the dark, while
rotating before being mounted on to positively charged glass slides(1358W; Globe Scientific) with
Vectashield hard set mounting medium (H-1400; Vector Labs) and micro glass cover slips(48393;
VWR). Slides were allowed to dry before sealing with clear nail polish.
To visualize the red fluorescence from tdT in the CCK;Dlx5/6 neurons and green fluorescence
from antibodies against the proteins mentioned above, a Nikon A1R laser-scanning confocal
fluorescence microscope was used. Fluorophores and their spectra were as follows
(excitation/emission (nm)): tdTomato (554/581), Alexa 488 (495/519), FITC (493/528), Alexa 647
(652/668), SYTO-13 (488/509, and TO-PRO-3 (642/661). Slices were never co-stained with
fluorescent proteins that had significant overlapping emission spectra. Images were taken at 10X
to view the TRN in its entirety, 20X to visualize individual tdT+ cells in the TRN. Brain slices with
multiple fluorescent proteins with overlapping wavelengths were scanned and imaged using a
spectral unmixing tool provided by the Nikon software package, NIS Elements. Pictures of one or

17

both TRNs per brain slice were taken, often in the form of 10X z stacks at slice thickness ranging
from 2 µm to 4 µm.
Confocal images were originally saved in .ND2 format on to a flash drive and later opened with
ImageJ Fiji for analysis. Cell counts were done manually using the Cell Counter plug in for FIJI
(https://imagej.nih.gov/ij/plugins/cell-counter.html). Cell counts were done for tdT+ cells
(CCK;Dlx5/6 neurons) within the TRN, and tdT+ cells that colocalized with the proteins of interest
(NeuN, PV, CCK, and CB1R). Colocalization of 2 different fluorescent proteins was also done
manually. To keep consistency across brain slices and individual mice, cell counts were done on
the max intensity projection of the Z stack collected. This combines all individual pictures taken
within the z stack to give a better representation of fluorescence throughout the entire slice.
To image larger brain regions when analyzing potential target areas of TRN CCK;Dlx5/6 neurons
throughout the thalamus, variations in surface focal point across the slice were adjusted
accordingly using the NIS software before scanning the whole image, with each picture sized at
1024. Individual z stacks taken at each focal point were then stitched together with 10 % overlap.
We measured corrected total area fluorescence (CACF) associated to different thalamic nuclei.
Areas that correspond to thalamic nuclei were drawn based on the Allen Brain Reference Atlas for
the adult mouse (Lein et al., 2007). All areas were drawn relative to the localization of the TRN,
which was easily distinguishable thanks to the strong tdT signal from CCK;Dlx5/6 neurons. CACF
was corrected for background fluorescence. CACF was calculated with the following formula:
CACF = Integrated Density – (Area x mean fluorescence of background). Integrated density is the
product

of

mean

fluorescence

by

the

area

for

each

drawn

for

each

nuclei

(https://theolb.readthedocs.io/en/latest/imaging/measuring-cell-fluorescence-using-imagej.html).
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The tdT fluorescence signal in all of our images was pseudcolored with magenta instead of red to
facilitate the interpretation of our results by people with color blindness.

3.4 Statistical analysis
Cell counts of tdT-expressing cells of the TRN manually counted using the ImageJ FIJI Cell
Counter Plugin were collected for every individual slice. To determine if tdT+ cells of the TRN
co-expressed any of the proteins of interest (NeuN, PV, CB1R, and CCK), the different channels
were merged with the tdT images for each slice and the cells that appeared to show co-localization,
often producing a yellow color as a result of red tdT and green secondary antibody of protein of
interest. The number of cells counted as expressing both tdT and the secondary antibody were then
divided by the total number of tdT cells to give an average of co-localization. If a mouse had
multiple brain slices stained and imaged, those averages would then be combined to give an overall
average of co-localization for that individual mouse. Averages and S.E.M. were calculated using
excel and plots were created with R programing language (or statistical software).
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4.0 RESULTS
4.1 Novel CCK;Dlx5/6 neurons identified in the TRN
Previous studies have shown the presence of mRNA for CCK in neurons as well as non-neuronal
tissue (Hökfelt T et al., 1991). Furthermore, some promoters can exhibit basal activity regardless
of the presence of their transcription factors leading to low unregulated gene expression (BittnerEddy, Fischer, & Costalonga, 2019), Because in the CCK;Dlx5/6;tdT mouse line we are utilizing
two promoters to label CCK;Dlx5/6 neurons, thereby increasing the possibility of finding
expression of tdT in non-neuronal tissue. To rule out this possibility, we first confirmed that
CCK;Dlx5/6 cells in the TRN are indeed neurons. We stained slices of CCK;Dlx5/6;tdT mice with
the neuronal marker NeuN. Next, we quantified the number of cells exhibiting fluorescent signals
for tdT and NeuN. We found that approximately 94.4% of tdT cells also express NeuN (mean ±
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Figure 5. Staining of CCK;Dlx5/6;tdT slices with NeuN identifies tdT+ cells within the TRN as
neurons. A. 10x confocal images of the TRN. Left, tdT in the TRN (magenta); Middle, NeuN
expression (green); Right, tdT and NeuN merged. Scale = 200 m. B. On average, 94.4% of
CCK;Dlx5/6 neurons in the TRN are positive for expression of NeuN across all samples. Data are
represented using a box plot with interquartile range and 95% confidence interval.
s.e.m. = 94.5 ± 1.06 %, n = 4, 2-4 slices per mouse. Figure 5A and 5B). No differences were
observed between males and females, and the tdT in the TRN labeling was consistent among
multiple litters and generations. This result strongly suggests that the vast majority of CCK;Dlx5/6
Figure XXX.
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cells in the TRN are neurons. Furthermore, our images show that CCK;Dlx5/6 neurons are
strikingly localized to the TRN because none of the cell bodies for these neurons was observed in
none of the relay or intralaminar nuclei (Figure 5A). Our results unveiled a novel neuronal
population that has not been characterized before in the TRN and that is distinguished with the
activity of CCK and Dlx5/6 promoters.

4.2 Distribution of the CCK;Dlx5/6 neurons in the TRN
As indicated above, the TRN is subdivided into three regions in head, body and tail (Perez et al.,
2017). Interestingly, head is associated to the processing of visual information, whereas cells in
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Figure 6. Relative distribution of CCK;Dlx5/6 neurons across the head, body, and tail regions
of the TRN. A. 10x confocal images of the TRN with the head, body, and tail regions segregated.
Left, tdT expression in the TRN (magenta). Middle, NeuN expression (green) across regions and the
dorsal thalamus. Right, tdT and NeuN expression merged. Scale = 200 m. B. Quantification of
CCK;Dlx5/6 neurons of the TRN across regions reveal that approximately 27.7% in the head, 18.6%
in the body, and 12.1% in the tail of NeuN+ neurons in the TRN express tdT, with the head region
having the highest concentration. Data are represented using a box plot with interquartile range and
95% confidence interval. Outliers were calculated as Q1 - (1.5 X IQR) and Q3 + (1.5 X IQR).
the body process somatosensory information, and the tail motor information (Pinault & Deschênes,
1998). To gain insights into the potential function of CCK;Dlx5/6 neurons in the TRN we
determined their relative abundance in each of the three regions. To determine the relative
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distribution of CCK;Dlx5/6 neurons , the TRN was separated into 3 regions: head, body, and tail
(Figure 6A). All confocal images used for data analysis were in the form of a single image that
combined every image within the z-stack for that given slice. By doing this, we disregarded
differences in distribution in terms of rostral vs caudal as some previous studies have done. We
quantified the amount of cells with signals for tdT and NeuN relative to the total number of NeuN+

tdT+/NeuN+ cells (%)

neurons throughout the TRN in each region (Figure 6A).
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Figure 7. Distribution of CCK;Dlx5/6 neurons in regions of the TRN per mouse. Comparison
of the relative proportion of CCK;Dlx5/6 neurons per region among individual mice. At least 3
slices per mouse were analyzed. Data are represented using a box plot with interquartile range
and 95% confidence interval.
Approximately 27.7 % of neurons within the head region express tdT, 18.6% of neurons in the
body express tdT, and 12.1% of neurons in the tail express tdT (% of CCK;Dlx5/6 neurons per
TRN region, mean ± s.e.m. head = 27.7 ± 3.0 %, body = 18.6 ± 1.3 %, tail = 12.1 ± 1.1 %. Figure
6B). Three individual t tests were run to compare concentration of neurons between the 3 regions.
The t test comparing the head and body region was p = 0.044, for the head and tail region was p =
0.0055, and body and tail was p = 0.0044. To correct for multiple comparisons, I used the
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Bonferroni correction and  was set at 0.016, thus all p values below 0.016 were considered
significant. The relative abundance of CCK;Dlx5/6 neurons was higher in the head than tail and
the body relative to the tail (Figure 6B). These results show that there is pattern of distribution of
CCK;Dlx5/6 neurons, where there is higher abundance of them in the dorsal region (head) relative
to the ventral region (tail). Our results were also consistent among individual mice (Figure 7).
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4.3 CCK;Dlx5/6 neurons in the TRN express the CCK peptide
The DNA recombination and thus tdT expression by Cre and Flpe recombinases is irreversible,
this opens the possibility that a transient expression of either or the two enzymes resulted in the
production of tdT at some point in development, without necessarily labeling neurons that express
the CCK peptide (Abremski & Hoess, 1984;Metzger & Feil, 1999). To rule out this possibility, we
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Figure 8. Expression of CCK peptide in CCK;Dlx5/6 neurons of the TRN. A. 10x
confocal images of coronal slices of the TRN. Left, tdT in the TRN (magenta); Middle,
CCK peptide expression (green); Right, tdT and CCK peptide merged. B. Quantification
CCK;Dlx5/6 neurons expressing CCK peptide in the TRN. Scale = 200 m. C.
Percentage of CCK;Dlx5/6 neurons in the TRN positive for expression of CCK peptide
is consistent across mice. Data are represented using a box plot with interquartile range
and 95% confidence interval. Outliers were calculated as Q1 – (1.5 X IQR) and Q3 +
(1.5 X IQR).
24

75
50
25
0

M1

performed immunohistochemistry experiments using an antibody against CCK. This experiment
is essential to provide a thorough characterization of the CCK;Dlx5/6 neurons in the TRN. Brain
slices from CCK;Dlx5/6;tdT mice were stained for the CCK peptide. We found that approximately
98.5% of CCK;Dlx5/6 neurons within the TRN expressed the CCK peptide (% of CCK;Dlx5/6
expressing CCK, mean ± s.e.m. = 98.5 ± 0.4%, n = 6 mice, 3-5 slices per mouse. Figure 8A-B).
This observation was also consistent across different mice (Figure 8C). We observed wide
expression of CCK in the TRN and thalamus, which is not surprising given that CCK is the most
abundant neuropeptide in the brain (Figure 8A). Our results strongly suggest that CCK;Dlx5/6
neurons in the TRN belong to a class of interneurons that express the CCK peptide in adulthood
and our intersectional strategy to label them is adequate.

4.4 CCK;Dlx5/6 neurons in the TRN partially express parvalbumin
As noted previously, it has been suggested that all neurons within the TRN expresses PV (Hou,
Smith, & Zhang, 2016). Although recent evidence suggests that there is another non-overlapping
population of interneurons expressing SST in the TRN (Perez et al., 2017). In the hippocampus
CCK+ and PV+ interneurons represent two non-overlapping classes of interneurons (Hefft & Jonas,
2005). Therefore, we tested if CCK;Dlx5/6 express PV in the TRN. We stained for PV using
antibodies against this protein. We found that approximately 58 % of CCK;Dlx5/6 neurons in the
TRN also express PV (% of CCK;Dlx5/6 neurons expressing PV, mean ± s.e.m. = 58.1 ± 5.7 %, n
= 4. Figure 9A and B). However, this observation was not consistent among different mice
(Figure 9C). Our results suggest that in terms of PV expression, there are two subpopulations of
CCK;Dlx5/6 neurons, one that expresses the PV peptide and one that does not.
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Figure 9. Expression of the PV peptide in CCK;Dlx5/6 neurons in the TRN. A. 10x confocal
images of the TRN. Left, tdT expression (magenta) in CCK/Dlx5/6 neurons. Middle, PV protein
(green) expression in the TRN and dorsal thalamus. Right, tdT and PV protein staining merged. B.
Approximately 58% of CCK;Dlx5/6 neurons in the TRN express the PV peptide when averaged
across 4 mice. Scale = 200 m. C. The percentage of CCK;Dlx5/6 neurons that also express PV
varied across mice. Data are represented using a box plot with interquartile range and 95%
confidence interval. Outliers were calculated as Q1 – (1.5 X IQR) and Q3 + (1.5 X IQR).
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4.5 CCK;Dlx5/6 neurons in the TRN express the cannabinoid receptor type 1
CCK+ interneurons from the hippocampus and amygdala have been shown to be enriched with
CB1R (Bowers & Ressler, 2014; Iball & Ali, 2011; Katona et al., 1999; Lee et al., 2010). Our
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Figure 10. Expression of CB1R in CCK;Dlx5/6 neurons of the TRN. A. 10x confocal images of
the TRN. Left, tdT (magenta) expression in CCK;Dlx5/6 neurons. Middle, CB1R (green) protein
staining. Right, CB1R expression merged with tdT expression. B. Approximately 98.8% of
CCK;Dlx5/6 neurons in the TRN express the CB1R protein averaged from 5 mice. Scale = 200 m.
C. Percentage of tdtom neurons in the TRN that express CB1R showed little variability between 5
mice. Data are represented using a box plot with interquartile range and 95% confidence interval.
Outliers were calculated as Q1 – (1.5 X IQR) and Q3 + (1.5 X IQR).
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laboratory confirmed these results in the CCK;Dlx5/6 mice using fluorescence activated cellsorting coupled to qRT-PCR (Bunda et al., 2019). Thus, we tested if CCK;Dlx5/6 neurons also
express CB1R in the TRN by staining for the CB1R. We found that approximately 98.8% of
CCK;Dlx5/6 neurons also express CB1R (% of CCK;Dlx5/6 neurons expressing CB1R, mean ±
s.e.m = 98.8 ± 0.19, n = 5 mice, 3-5 slices per mouse. Figure 10A and B). Furthermore, this
observation was consistent across different mice (Figure 10C). Our results suggest that similar to
CCK+ interneurons from other areas of the brain, CCK;Dlx5/6 also express the CB1R.

4.6 CCK;Dlx5/6 neurons target multiple areas of the thalamus
To start elucidating the potential target areas of the CCK;Dlx5/6 neurons in the TRN, we took
advantage of the ability of tdT to travel to via axons to the synaptic terminals(Besser et al., 2015;
Fujita, Nakanishi, Ueno, Itohara, & Yamashita, 2020; Kim et al., 2020), as well as from previous
knowledge showing that TRN is the only thalamic nuclei that does not project outside of the
thalamus (Pinault, 2004). Next, using as reference the Adult Mouse Brain Atlas from the Allen
Institute (Lein et al, 2007), we estimated the subdivisions of the thalamus and the approximate
position of each area relative to the TRN (Figure 11A and B). We readily identified the following
nuclei: medial habenula (MH), lateral habenula (LH) (Figure 11C), lateral dorsal (LD) (Figure
11D), mediodorsal (MD) and paracentral (PCN) (Figure 11E), ventral posterolateral (VPL) and
ventral posteromedial (VPM) (Figure 11F), ventral anterior-lateral (VAL), ventral medial (VM)
and submedial nucleus (SMT) (Figure 11G), and the posterior complex (PO) (Figure 11H). Next,
we quantified the fluorescence in each of these putative regions of the thalamus. It is important to
note that the fluorescent signal from tdT is associated with axons and synaptic terminals, although
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not ideal to determine synaptic targets, this represents a first step to assess the thalamic areas that
are likely be targeted by CCK;Dlx5/6 neurons.

29

Figure 11. Target thalamic areas of CCK;Dlx5/6 neurons. A. Confocal image of the TRN and
adjacent relay nuclei outlined from CCK;Dlx5/6 slices. B. A visual representation of the thalamic
nuclei seen in A., according to Allen Brain Atlas C. Relatively small amount of tdT seen in the
medial habenula (MH) and lateral habenula (LH) D. tdT appears to be highly expressed in the
laterodorsal nucleus (LD) E. tdT expression in the mediodorsal (MD) and paracentral nucleus
(PCN) F. Abundant tdT axons expressed in both the ventral posterolateral (VPL) and ventral
posteromedial nucleus (VPM) G. tdT expression in the ventral anterior-lateral (VAL), ventral
medial (VM), and submedial nucleus (SMT) H. tdT axon collaterals in the posterior complex (PO).
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Figure 12. Fluorescence corrected by background in different thalamic areas. Quantitative
data of tdT axons and synaptic terminals expressed as fluorescence are presented as mean and s.e.m.
At least three images from different mice were used for this analysis.

We found that thalamic areas with the highest fluorescence corrected by background were the LD,
VPL, and VPM, whereas MD, VM, SMT and CL showed less fluorescence (Figure 12). These
preliminary observations suggest that CCK;Dlx5/6 neurons are more likely to expand their axons
and terminals to dorsal and ventral posterior areas rather than medial and ventral medial areas.
Finally, a high magnification in the LD of brain slices stained with SYTO-13 (a cell body marker)
shows that CCK;Dlx5/6 neurons form perisomatic synapses around target neurons (Figure 13,
insets). This is in accordance with previous studies of CCK interneurons from the hippocampus
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and amygdala. However, our current analysis does not allow to discard the possibility that these
neurons also form synapses.

Figure 13. High magnification image of the LD in slices of CCK;Dlx5/6;tdT mice. Several
insets were digitally magnified to observe putative synaptic buttons (magenta) around cell bodies
(green) of target cells located in the LD. Axons are clearly seen in the non-digitally magnified
image (top left panel, 60X). A-C: White arrows point at putative synaptic buttons, characterized
by their morphology.
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5.0 DISCUSSION
An easy way to drive home the function of TRN in sensory processing is referring to research that
has completely removed it from the brain. However, this does not tell the whole story and isn’t
quite applicable to sensory disorders in humans where the TRN is never completely absent.
Removing the TRN and therefore removing this inhibitory feedback and integration of signals is
not nearly the same thing as the TRN being present but integrating signals in the wrong way. It
needs to be remembered that the TRN is right in the middle of this bigger circuit where multiple
parts are contributing to it working properly. For example, if the cortical neurons/driver inputs are
dysfunctional, do we know that the TRN is able to compensate for this? It is manipulation of
specific cell types, gene expression, neurotransmitters/neuromodulators that give us the best
insight.
My results show that more than a quarter of neurons in the TRN that are part of the head and tail
are CCK;Dlx5/6 neurons. The head and body of the TRN are two regions associated with
processing of visual and somatosensory information, respectively (Clemente-Perez et al., 2017;
Crabtree, 2018; Pinault & Deschênes, 1998). This opens the possibility that CCK;Dlx5/6 neurons
in the TRN fine tune visual and somatosensory information on its way or back from the cortex.
My immunohistochemistry analysis for the PV staining in brain slices from CCK;Dlx5/6;tdT mice
show two CCK;Dlx5/6 population one expressing PV and another without the PV peptide. This
potential difference could arise from incomplete staining with the PV antibody. Previous reports
have shown that more than 95% of the TRN neurons express PV, however this may heavily depend
on the antibody and incubation conditions. We utilized a shorter incubation time than previously
reported, thus it is possible that our staining conditions did not capture CCK;Dlx5/6 neurons with
low PV expression.
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My results also show that almost all CCK;Dlx5/6 neurons express the CCK peptide. This is
important because suggest that the labeling of these neurons by tdT reflects the adult phenotype of
CCK;Dlx5/6 neurons and is not the result of transient expression of Cre and Flpe recombinases
during development. The CCK peptide within itself is an exciting peptide to study because it has
been implicated in anxiety(Bowers, Choi, & Ressler, 2012; Keimpema, Straiker, Mackie, Harkany,
& Hjerling-Leffler, 2012; Lach, Schellekens, Dinan, & Cryan, 2018) and manic-like
behaviors(Arey et al., 2014). However, its role in the thalamus has not been previously described
and the mechanisms of release for CCK from CCK;Dlx5/6 neurons is not known.
Exogenous cannabinoids in humans cause symptoms such as hypersensitivity to visual and
auditory stimuli sometimes leading to hallucinations, reduced working memory, trouble
coordinating movements, impulsivity, difficulty concentrating, altered sense of time, and general
changes in mood (NIDA, 2019). As my results indicate, almost all CCK;Dlx5/6 neurons in the
TRN also express the CB1R. This can be significant to explain the enhanced sensitivity to sensory
cues induced by cannabinoids. The activation of CB1R inhibits release of neurotransmitters
including GABA, thus it is predicted that CB1R agonists such cannabinoids would suppress
CCK;Dlx5/6 neurons leading to disinhibition (lack of filtering) of sensory information traveling to
and back from the cortex.
Interestingly, our preliminary evidence shows that cells in the LD receive perisomatic connections
from CCK;Dlx5/6 neurons, likely from the head. The LD is a HO thalamic nucleus that process
sensory information arriving from the visual cortex, this nucleus also sends connections to the
limbic system (Aggleton, Saunders, Wright, & Vann, 2014; Perry & Mitchell, 2019). It is thought
that the LD is involved in assessing the emotional component of visual stimuli, mainly aversive
stimuli, by relaying information between the amygdala and higher brain structures (Zanoveli et al.,
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2007). This observation allows to formulate the idea that CCK;Dlx5/6 neurons are finetuning
emotional responses to sensory cues. However, behavior studies to target CCK;Dlx5/6 neurons
connecting to the LD will be necessary to determine their role in visual processing. Furthermore,
our initial evidence also showed that CCK;Dlx5/6 connects to the VPL and VPM, both nuclei relay
somatosensory information including nociceptive information. The VPL relays spinothalamic
connections, whereas the VPM receives trigeminothalamic inputs. Thus, it is possible that
CCK;Dlx5/6 neurons in the TRN are also linked to processing of pain at the central level (Andrew,
May, & Warren, 2020; Youssef et al., 2019). Interestingly, CCK interneurons in the hippocampus
and cortex have been linked to emotional processing, and CCK interneurons in the spinal cord
have been linked to nociception(Bowers & Ressler, 2015; Brown et al., 2014; Truitt, Johnson,
Dietrich, Fitz, & Shekhar, 2009;Freund, 2003).
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6.0 FUTURE DIRECTIONS
6.1 What are the electrophysiological properties of CCK;Dlx5/6 neurons in the TRN?
To better understand the function of these neurons within the TRN, we need to determine their
electrophysiological properties. This is particularly important for this area of the brain where the
other 2 major cell populations in the TRN, PV and SST, have been described as having firing
properties that are either fast-spiking or regular spiking and typically synchronous release of NT.
CCK;Dlx5/6 neurons in other areas of the brain appear to be regular-spiking with asynchronous
release of NT, which is thought to create long-lasting inhibition onto post-synaptic targets. The
TRN controls activity of the relay thalamic nuclei in part by switching between tonic and burst
firing and therefore these CCK;Dlx5/6 neurons may play an important in this process that is not
accomplished by other cell populations previously established in the TRN.

6.2 What are the synaptic properties of CCK;Dlx5/6 neurons in the TRN?
CCK neurons in other areas of the brain have been shown to release NT in an asynchronous
manner, which leads to long-lasting inhibition. This feature of this cell type could help us
understand the impact of these neurons within the TRN onto post-synaptic targets. Other synaptic
properties to explore could be number of the number of release sites. In other areas of the brain,
CCK neurons are also shown to rely on N-type calcium channels as opposed to P/Q-type channels
that PV neurons rely on to release NT. We could stain CCK;Dlx5/6;Tdt brain slices with a marker
for axonal terminals. Relative distribution and concentration of these terminals in specific areas
could correlate to the amount of impact these neurons have on those post-synaptic targets.
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6.3 What neurons do CCK;Dlx5/6 neurons in the TRN target?
Identifying post-synaptic target sites of these neurons will provide an important missing piece to
the puzzle, especially when sectors of the TRN correspond to specific functional modalities and
the relay nuclei that they target are also specific and functionally distinct from one another. It has
been established that individual TRN neurons that target more than one relay nuclei are targeting
areas that are associated with the same modality. Exploring if CCK;Dlx5/6 neurons of the TRN
target other TRN neurons would also give us insight into how intra-TRN activity affects the output
of these neurons. To accomplish establishing these post-synaptic targets, it may be necessary to
develop an anterograde tracer capable of specifically targeting CCK;Dlx5/6 neurons of the TRN.

6.4 What behaviors are under the control of or are influenced by CCK;Dlx5/6 neurons in the
TRN?
Once electrophysiological and synaptic properties of these neurons, as well as their post-synaptic
targets are established, it will be easier to speculate what behaviors they may be specifically
controlling and allow for the design of relevant behavioral experiments. For example, if these
neurons preferentially target the LD of the thalamus that has been suggested to play a role in limbic
function, it would make sense to design an experiment that confirm what this means on a
behavioral level. Ways to accomplish that may be to have mice participate in a task that involves
the proper recognition of stimuli that is novel vs something that has been conditioned to induce an
emotional response (or some other task associated with LD function), such as fear. Then by
selectively activating or silencing CCK;Dlx5/6 neurons of the TRN and having these mice once
again complete the same task, we would expect to see a difference in behavior.
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Although PV interneurons of the TRN are thought to drive spindles during NREM sleep
(Thankachan et al., 2019), the activity of CCK;Dlx5/6 neurons on PV+ neurons should be
considered. Release of CCK from CCK+ neurons preferentially target PV neurons, leading to
inhibition of PV neurons. The delicate balance between tonic and burst firing is required for
spindles, as is synchronous oscillations. It could be hypothesized that in order for PV neurons to
maintain spindles, CCK;Dlx5/6 neurons would need to be inhibited somehow- leading to
disinhibition of TRN PV neurons.

6.5 How do CCK;Dlx5/6 neurons interact with cannabinoids to control TRN’s interaction
with relay thalamic nuclei?
It has been well established that CB1R and cannabinoids play a significant role in behaviors such
as sleep maintenance, sensory processing, working memory. The effect that cannabinoids have on
electrophysiological and synaptic processes of CCK;Dlx5/6 neurons of the TRN could first be
investigated with slice electrophysiology and the application of CB1R antagonists and agonists.
Once the impact of cannabinoids on these electrical properties is determined, it could then be
applied at the in vivo level during behavioral tasks that have been established to be related to the
function of these neurons within the TRN. For example, using the behavioral experiment
mentioned above, at each stage: no manipulation, silencing, and activating these neurons,
cannabinoids could be introduced to provide greater detail into how this cell population is
coordinating with cannabinoids to control output and subsequently behavior.

6.6 What role do CCK;Dlx5/6 neurons of the TRN play in disease?
Many diseases that have been shown or suggested to be related to dysfunction of the TRN are
those of neurodevelopmental disorders previously discussed. Once properties of these neurons and
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the behaviors in which they have an influence over have been established, it should be easier to
narrow down what specific symptoms of these disorders that these neurons may contribute to.
The next step may be to investigate changes in this cell population within the TRN over
development, particularly at critical periods involved in the development of spindle activity and
sensorimotor circuits. This could be done by either evaluating connections of CCK;Dlx5/6 neurons
onto dorsal thalamic nuclei in post-mortem tissue at different points in development or selectively
silencing these neurons at different periods in development and observe behavioral phenotypes
compared to littermates who did not have these neurons silenced.
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